Dr. Reddy's Gets Five US FDA Observations For Hyderabad Plant - BloombergQuint

BloombergQuint
Dr. Reddy's Gets Five US FDA Observations For Hyderabad Plant
BloombergQuint
Drugmaker Dr. Reddy's Laboratories Ltd. has received five observations from the U.S. health regulator for its active pharmaceutical ingredient plant at Medak in Telangana. The observations are related to procedures and facilities maintenance, Dr. Reddy ...and more »